Pad Chivukula, Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc. (ARCT), sold 34,870 shares at $35.02 ($1.2M) on 2024-03-25, disclosed to the SEC on 2024-03-27.
Scheduled sale ($1.2M) by Chief Scientific Officer & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.02 | 17,435 | $611K | 50.0% |
| 2 | $35.02 | 17,435 | $611K | 50.0% |
| Total | $35.02 avg | 34,870 | $1.2M | 100% |
| Filing → |
| ARCT | SELL | 2024-06-04 | $1.0M | — | Filing → |
| ARCT | SELL | 2024-03-21 | $600K | — | Filing → |
| ARCT | SELL | 2023-11-03 | $94K | — | Filing → |